The sleeping aids market size has grown strongly in recent years. It will grow from $95.12 billion in 2025 to $102.13 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising insomnia prevalence, increased work-related stress, urban lifestyle changes, growth in otc drug availability, awareness campaigns on sleep disorders.
The sleeping aids market size is expected to see strong growth in the next few years. It will grow to $137.07 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to aging demographics, growth in wearable sleep devices, rising digital therapeutics adoption, increased diagnosis rates, innovation in natural sleep aids. Major trends in the forecast period include increased use of OTC sleep supplements, integration of AI-based sleep tracking, growth of non-habit-forming formulations, rising demand for home-based sleep therapy, expansion of online pharmacy channels.
The rising global aging population is expected to drive the growth of the sleeping aid market in the coming years. The term “aging population” refers to changes in a population’s age distribution that result in a higher proportion of elderly individuals. The demand for sleep-related solutions is increasing due to various age-related factors that can cause sleep disturbances and disorders, making the need for sleeping aids largely driven by the aging population. For example, in May 2024, the Administration for Community Living, a US-based government agency, reported that in 2022, 17.3% of the population was aged 65 or older. This proportion is projected to rise to 22% by 2040. Consequently, the growing global aging population is fueling the expansion of the sleeping aid market.
Key companies in the sleeping aids market are focusing on strategic partnerships with major manufacturers to strengthen their market position. Strategic collaborations allow companies to leverage the expertise of partner firms to turn innovative concepts into practical solutions. For instance, in October 2023, EnsoData, Inc., a US-based software company providing AI solutions for sleep testing, diagnosis, and treatment, announced a strategic partnership with React Health, a US-based sleep and respiratory device manufacturer, to enhance PAP adherence support for patients with sleep apnea. Through this collaboration, suppliers of durable medical equipment and referring physicians can access actionable data to provide timely, personalized support to patients struggling with treatment adherence.
In October 2025, Alkermes Plc, an Ireland-based biopharmaceutical company, acquired Avadel Pharmaceuticals for $2.1 billion. This acquisition enables Alkermes to expand its presence in the sleep medicine market, strengthen its product portfolio with Avadel’s late-stage pipeline, and combine R&D capabilities to accelerate the development and commercialization of innovative therapies for sleep disorders. Avadel Pharmaceuticals is an Ireland-based specialty pharmaceutical company focused on the development and commercialization of treatments for sleep disorders.
Major companies operating in the sleeping aids market are Cadwell Industries Inc., Compumedics Limited, DeVilbiss Healthcare Pvt. Ltd., Natus Medical Incorporated, Sleepmed Inc., ResMed Inc., Fisher & Paykel Healthcare Corporation Limited, Braebon Medical Corporation, Löwenstein Medical GmbH & Co. KG, Koninklijke Philips N.V., Apnea Sciences Corp., BMC Medical Co. Ltd., Cleveland Medical Devices Inc., Serta Simmons Bedding LLC, Tempur Sealy International Inc., Sleep Number Corporation, Casper Sleep Inc., Purple Innovation Inc., Leesa Sleep LLC, Lowenstein Medical.
North America was the largest region in the sleeping aids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping aids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sleeping aids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have affected the sleeping aids market by increasing the cost of imported mattresses, sleep apnea devices, pharmaceutical ingredients, and herbal supplements. Retail pharmacies, e-commerce platforms, and hospitals in Asia-Pacific and Europe are most impacted due to dependence on global suppliers. These higher costs can push up consumer prices across prescription, OTC, and device segments. However, tariffs are encouraging domestic production of sleep products and medical devices, strengthening long-term supply stability in the sleeping aids market.
The sleeping aids market research report is one of a series of new reports that provides sleeping aids market statistics, including sleeping aids industry global market size, regional shares, competitors with a sleeping aids market share, detailed sleeping aids market segments, market trends and opportunities, and any further data you may need to thrive in the sleeping aids industry. This sleeping aids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Sleeping aids are a category of psychoactive medications used to treat insomnia and occasional sleeplessness. They help reduce daytime fatigue and cognitive impairment caused by lack of sleep.
The main types of sleeping aids include mattresses and pillows, sleep laboratories, medications, prescription drugs, over-the-counter (OTC) drugs, herbal remedies, and sleep apnea devices. Medications refer to formulations containing one or more active and/or inactive ingredients. These aids are indicated for conditions such as insomnia, sleep deprivation, narcolepsy, sleep apnea, and others. They are distributed through hospital pharmacies, retail pharmacies, e-commerce platforms, sleep aid stores, drug stores, and other channels.
The sleeping aids market consists of sales of insomnia treatment drugs, quazepam, narcolepsy treatment drugs, modafinil, and sodium oxybate. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The sleeping aids market size is expected to see strong growth in the next few years. It will grow to $137.07 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to aging demographics, growth in wearable sleep devices, rising digital therapeutics adoption, increased diagnosis rates, innovation in natural sleep aids. Major trends in the forecast period include increased use of OTC sleep supplements, integration of AI-based sleep tracking, growth of non-habit-forming formulations, rising demand for home-based sleep therapy, expansion of online pharmacy channels.
The rising global aging population is expected to drive the growth of the sleeping aid market in the coming years. The term “aging population” refers to changes in a population’s age distribution that result in a higher proportion of elderly individuals. The demand for sleep-related solutions is increasing due to various age-related factors that can cause sleep disturbances and disorders, making the need for sleeping aids largely driven by the aging population. For example, in May 2024, the Administration for Community Living, a US-based government agency, reported that in 2022, 17.3% of the population was aged 65 or older. This proportion is projected to rise to 22% by 2040. Consequently, the growing global aging population is fueling the expansion of the sleeping aid market.
Key companies in the sleeping aids market are focusing on strategic partnerships with major manufacturers to strengthen their market position. Strategic collaborations allow companies to leverage the expertise of partner firms to turn innovative concepts into practical solutions. For instance, in October 2023, EnsoData, Inc., a US-based software company providing AI solutions for sleep testing, diagnosis, and treatment, announced a strategic partnership with React Health, a US-based sleep and respiratory device manufacturer, to enhance PAP adherence support for patients with sleep apnea. Through this collaboration, suppliers of durable medical equipment and referring physicians can access actionable data to provide timely, personalized support to patients struggling with treatment adherence.
In October 2025, Alkermes Plc, an Ireland-based biopharmaceutical company, acquired Avadel Pharmaceuticals for $2.1 billion. This acquisition enables Alkermes to expand its presence in the sleep medicine market, strengthen its product portfolio with Avadel’s late-stage pipeline, and combine R&D capabilities to accelerate the development and commercialization of innovative therapies for sleep disorders. Avadel Pharmaceuticals is an Ireland-based specialty pharmaceutical company focused on the development and commercialization of treatments for sleep disorders.
Major companies operating in the sleeping aids market are Cadwell Industries Inc., Compumedics Limited, DeVilbiss Healthcare Pvt. Ltd., Natus Medical Incorporated, Sleepmed Inc., ResMed Inc., Fisher & Paykel Healthcare Corporation Limited, Braebon Medical Corporation, Löwenstein Medical GmbH & Co. KG, Koninklijke Philips N.V., Apnea Sciences Corp., BMC Medical Co. Ltd., Cleveland Medical Devices Inc., Serta Simmons Bedding LLC, Tempur Sealy International Inc., Sleep Number Corporation, Casper Sleep Inc., Purple Innovation Inc., Leesa Sleep LLC, Lowenstein Medical.
North America was the largest region in the sleeping aids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping aids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sleeping aids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have affected the sleeping aids market by increasing the cost of imported mattresses, sleep apnea devices, pharmaceutical ingredients, and herbal supplements. Retail pharmacies, e-commerce platforms, and hospitals in Asia-Pacific and Europe are most impacted due to dependence on global suppliers. These higher costs can push up consumer prices across prescription, OTC, and device segments. However, tariffs are encouraging domestic production of sleep products and medical devices, strengthening long-term supply stability in the sleeping aids market.
The sleeping aids market research report is one of a series of new reports that provides sleeping aids market statistics, including sleeping aids industry global market size, regional shares, competitors with a sleeping aids market share, detailed sleeping aids market segments, market trends and opportunities, and any further data you may need to thrive in the sleeping aids industry. This sleeping aids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Sleeping aids are a category of psychoactive medications used to treat insomnia and occasional sleeplessness. They help reduce daytime fatigue and cognitive impairment caused by lack of sleep.
The main types of sleeping aids include mattresses and pillows, sleep laboratories, medications, prescription drugs, over-the-counter (OTC) drugs, herbal remedies, and sleep apnea devices. Medications refer to formulations containing one or more active and/or inactive ingredients. These aids are indicated for conditions such as insomnia, sleep deprivation, narcolepsy, sleep apnea, and others. They are distributed through hospital pharmacies, retail pharmacies, e-commerce platforms, sleep aid stores, drug stores, and other channels.
The sleeping aids market consists of sales of insomnia treatment drugs, quazepam, narcolepsy treatment drugs, modafinil, and sodium oxybate. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Sleeping Aids Market Characteristics
3. Sleeping Aids Market Supply Chain Analysis
4. Global Sleeping Aids Market Trends and Strategies
5. Sleeping Aids Market Analysis of End Use Industries
7. Global Sleeping Aids Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Sleeping Aids Total Addressable Market (TAM) Analysis for the Market
9. Sleeping Aids Market Segmentation
10. Sleeping Aids Market Regional and Country Analysis
11. Asia-Pacific Sleeping Aids Market
12. China Sleeping Aids Market
13. India Sleeping Aids Market
14. Japan Sleeping Aids Market
15. Australia Sleeping Aids Market
16. Indonesia Sleeping Aids Market
17. South Korea Sleeping Aids Market
18. Taiwan Sleeping Aids Market
19. South East Asia Sleeping Aids Market
20. Western Europe Sleeping Aids Market
21. UK Sleeping Aids Market
22. Germany Sleeping Aids Market
23. France Sleeping Aids Market
24. Italy Sleeping Aids Market
25. Spain Sleeping Aids Market
26. Eastern Europe Sleeping Aids Market
27. Russia Sleeping Aids Market
28. North America Sleeping Aids Market
29. USA Sleeping Aids Market
30. Canada Sleeping Aids Market
31. South America Sleeping Aids Market
32. Brazil Sleeping Aids Market
33. Middle East Sleeping Aids Market
34. Africa Sleeping Aids Market
36. Sleeping Aids Market Competitive Landscape and Company Profiles
37. Sleeping Aids Market Other Major and Innovative Companies
40. Sleeping Aids Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Sleeping Aids Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses sleeping aids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for sleeping aids? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sleeping aids market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Mattresses And Pillows; Sleep Laboratories; Medications; Prescription-Based Drugs; OTC Drugs; Herbal Drugs; Sleep Apnea Devices2) By Indication: Insomnia; Sleep Deprivation; Narcolepsy; Sleep Apnea; Other Indications
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; E-Commerce; Drug Stores; Other Distribution Channels
Subsegments:
1) By Mattresses And Pillows: Memory Foam Mattresses; Latex Mattresses; Airbed Mattresses; Waterbed Mattresses; Cervical Pillows; Contoured Pillows2) By Sleep Laboratories: Sleep Disorder Diagnostic Services; Polysomnography; Home Sleep Testing Services
3) By Medications: Prescription-Based Drugs; Over-The-counter (OTC) Drugs; Herbal And Natural Remedies
4) By Prescription-Based Drugs: Benzodiazepines; Non-Benzodiazepines; Antidepressants; Antihistamines
5) By OTC Drugs: Antihistamines (Diphenhydramine, Doxylamine); Melatonin Supplements; Herbal Sleep Aids
6) By Herbal Drugs: Valerian Root; Chamomile; Lavender; Passionflower; Lemon Balm
7) By Sleep Apnea Devices: Continuous Positive Airway Pressure (CPAP) Devices; Bi-level Positive Airway Pressure (BiPAP) Devices; Adaptive Servo-Ventilation (ASV) Devices; Oral Appliances; Masks
Companies Mentioned: Cadwell Industries Inc.; Compumedics Limited; DeVilbiss Healthcare Pvt. Ltd.; Natus Medical Incorporated; Sleepmed Inc.; ResMed Inc.; Fisher & Paykel Healthcare Corporation Limited; Braebon Medical Corporation; Löwenstein Medical GmbH & Co. KG; Koninklijke Philips N.V.; Apnea Sciences Corp.; BMC Medical Co. Ltd.; Cleveland Medical Devices Inc.; Serta Simmons Bedding LLC; Tempur Sealy International Inc.; Sleep Number Corporation; Casper Sleep Inc.; Purple Innovation Inc.; Leesa Sleep LLC; Lowenstein Medical
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Sleeping Aids market report include:- Cadwell Industries Inc.
- Compumedics Limited
- DeVilbiss Healthcare Pvt. Ltd.
- Natus Medical Incorporated
- Sleepmed Inc.
- ResMed Inc.
- Fisher & Paykel Healthcare Corporation Limited
- Braebon Medical Corporation
- Löwenstein Medical GmbH & Co. KG
- Koninklijke Philips N.V.
- Apnea Sciences Corp.
- BMC Medical Co. Ltd.
- Cleveland Medical Devices Inc.
- Serta Simmons Bedding LLC
- Tempur Sealy International Inc.
- Sleep Number Corporation
- Casper Sleep Inc.
- Purple Innovation Inc.
- Leesa Sleep LLC
- Lowenstein Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 102.13 Billion |
| Forecasted Market Value ( USD | $ 137.07 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
